<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM THE
UNAUDITED  FINANCIAL  STATEMENTS  OF MEDICAL  TECHNOLOGY  SYSTEMS,  INC. FOR THE
TWELVE MONTHS ENDED MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                                          0000823560
<NAME>                   Medical Technology Systems, Inc.
<MULTIPLIER>                                         1000
<CURRENCY>                                             US

<S>                                           <C>
<PERIOD-TYPE>                                      12-Mos
<FISCAL-YEAR-END>                             Mar-31-2000
<PERIOD-START>                                Apr-01-1999
<PERIOD-END>                                  Mar-31-2000
<EXCHANGE-RATE>                                      1.00
<CASH>                                                172
<SECURITIES>                                            0
<RECEIVABLES>                                       2,875
<ALLOWANCES>                                         (274)
<INVENTORY>                                         2,030
<CURRENT-ASSETS>                                    4,889
<PP&E>                                              6,718
<DEPRECIATION>                                     (4,814)
<TOTAL-ASSETS>                                      7,866
<CURRENT-LIABILITIES>                               3,187
<BONDS>                                                 0
                                   1
                                             1
<COMMON>                                               65
<OTHER-SE>                                         (9,103)
<TOTAL-LIABILITY-AND-EQUITY>                        7,866
<SALES>                                            16,981
<TOTAL-REVENUES>                                   16,981
<CGS>                                               9,170
<TOTAL-COSTS>                                      15,767
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                  1,159
<INCOME-PRETAX>                                     1,214
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                                 1,214
<DISCONTINUED>                                      1,285
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                        2,499
<EPS-BASIC>                                           .39
<EPS-DILUTED>                                         .39



</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission